• LAST PRICE
    18.2250
  • TODAY'S CHANGE (%)
    Trending Down-0.5550 (-2.9553%)
  • Bid / Lots
    18.1500/ 7
  • Ask / Lots
    18.3000/ 7
  • Open / Previous Close
    18.8300 / 18.7800
  • Day Range
    Low 18.0400
    High 19.0899
  • 52 Week Range
    Low 3.0334
    High 61.9000
  • Volume
    144,541
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 18.78
TimeVolumeCRBP
09:32 ET451718.5501
09:33 ET157719
09:35 ET50018.98
09:37 ET484518.87
09:39 ET40018.985
09:42 ET261819.0899
09:44 ET30019
09:46 ET70018.85
09:48 ET25818.8
09:50 ET10018.82
09:51 ET51418.7101
09:53 ET13018.72
09:55 ET21618.72
09:57 ET280018.88
10:00 ET120018.8
10:02 ET40018.755
10:04 ET138518.725
10:06 ET110018.7305
10:08 ET50018.6835
10:09 ET270818.625
10:11 ET40018.69
10:13 ET30018.75
10:15 ET20018.7575
10:18 ET231618.87
10:20 ET30018.83
10:22 ET84718.83
10:24 ET10018.835
10:26 ET76418.78
10:27 ET30018.725
10:29 ET50018.7196
10:33 ET138618.6672
10:36 ET50018.82
10:38 ET20018.815
10:40 ET40018.79
10:42 ET11018.77
10:44 ET150018.71
10:45 ET10018.6307
10:47 ET41018.6368
10:49 ET10018.63
10:51 ET10018.69
10:54 ET10018.63
10:56 ET630118.535
11:05 ET60018.62
11:07 ET137018.72
11:12 ET80018.66
11:14 ET72018.665
11:16 ET70018.71
11:18 ET20018.7
11:21 ET27818.66
11:23 ET20018.6983
11:25 ET400318.735
11:30 ET1135818.585
11:32 ET10018.61
11:41 ET97918.7
11:45 ET42018.7036
11:50 ET160018.595
11:54 ET357618.46
11:56 ET20018.4
11:57 ET28218.35
11:59 ET26018.2201
12:01 ET100018.3376
12:06 ET100018.33
12:08 ET60018.3
12:12 ET30018.35
12:14 ET100018.25
12:15 ET20018.28
12:19 ET804118.23
12:24 ET293018.1201
12:28 ET30018.11
12:30 ET10018.15
12:33 ET10018.1744
12:42 ET231018.14
12:44 ET10018.095
12:51 ET132718.14
12:53 ET30018.15
12:55 ET320018.24
12:57 ET10018.27
01:00 ET54118.275
01:02 ET10318.275
01:04 ET60118.2184
01:08 ET51618.165
01:13 ET115218.15
01:15 ET60018.1498
01:18 ET40018.15
01:22 ET20018.13
01:24 ET10018.095
01:26 ET20018.06
01:27 ET40018.095
01:29 ET130018.04
01:31 ET100018.17
01:33 ET30018.21
01:38 ET10018.19
01:42 ET568218.275
01:45 ET30018.27
01:49 ET84018.355
01:51 ET20018.33
01:54 ET10018.315
01:58 ET30218.32
02:02 ET80018.2
02:03 ET10018.225
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCRBP
Corbus Pharmaceuticals Holdings Inc
228.7M
-3.1x
---
United StatesKYTX
Kyverna Therapeutics Inc
228.2M
0.0x
---
United StatesXBIT
XBiotech Inc
230.0M
-6.3x
---
United StatesNKTX
Nkarta Inc
225.1M
-1.7x
---
United StatesTRVI
Trevi Therapeutics Inc
223.7M
-6.8x
---
United StatesSLDB
Solid Biosciences Inc
234.5M
-1.9x
---
As of 2024-11-11

Company Information

Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.

Contact Information

Headquarters
500 River Ridge DriveNORWOOD, MA, United States 02062
Phone
617-963-0103
Fax
---

Executives

Independent Director
Alan Holmer
Chief Executive Officer, Director
Yuval Cohen
Chief Financial Officer
Sean Moran
Chief Medical Officer
Dominic Smethurst
Independent Director
Anne Altmeyer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$228.7M
Revenue (TTM)
$0.00
Shares Outstanding
12.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.60
EPS
$-5.82
Book Value
$-1.56
P/E Ratio
-3.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.